Vtv Theraptcs Cl A (VTVT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -21,525 | -12,985 | -5,774 | -25,073 | -18,983 |
| Depreciation Amortization | 67 | 45 | 22 | 92 | 69 |
| Accounts receivable | 173 | 173 | 173 | -116 | N/A |
| Other Working Capital | 3,108 | 3,156 | 1,896 | 5,385 | 6,205 |
| Other Operating Activity | 2,010 | -1,722 | -1,483 | 3,690 | 3,567 |
| Operating Cash Flow | $-16,167 | $-11,333 | $-5,166 | $-16,022 | $-9,142 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | -21 | -21 |
| Investing Cash Flow | $N/A | $N/A | $N/A | $-21 | $-21 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 566 | N/A | N/A | 776 | 776 |
| Common Stock Issued | N/A | N/A | N/A | 14,786 | 10,786 |
| Other Financing Activity | 11,713 | 11,806 | 11,806 | -808 | -475 |
| Financing Cash Flow | $12,279 | $11,806 | $11,806 | $14,754 | $11,087 |
| Beginning Cash Position | 12,126 | 12,126 | 12,126 | 13,415 | 13,415 |
| End Cash Position | 8,238 | 12,599 | 18,766 | 12,126 | 15,339 |
| Net Cash Flow | $-3,888 | $473 | $6,640 | $-1,289 | $1,924 |
| Free Cash Flow | |||||
| Operating Cash Flow | -16,167 | -11,333 | -5,166 | -16,022 | -9,142 |
| Capital Expenditure | N/A | N/A | N/A | -21 | -21 |
| Free Cash Flow | -16,167 | -11,333 | -5,166 | -16,043 | -9,163 |